feed

S&P 500—

NASDAQ—

DOW—

RUSSELL—

VIX—

US10Y—

DXY—

EUR/USD—

GBP/USD—

GOLD—

WTI—

BTC—

ETH—

AArphraTerminal

Arphra/Issuer/RVMD

RVMD

Revolution Medicines, Inc.

HealthcareBiotechnologyUSUSD

$157.48

Live · FMPMay 29, 2026

Market cap

$33.48B

52w range

34.00 – 158.13

P / E

—

EPS

—

Volume

6.66M

Revenue · FY

—

Press releasestopic:all earnings guidance dividend buyback mna ipo split layoffs lawsuit regulation rating executive product macro

News sentiment · 90d

DB · scored

2026-05-01 bullish neutral bearish2026-05-06

Topic mix · 30d

DB · scored

regulation1.001

News

DB · scored3

Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer
May 06, 2026GlobeNewsWire
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress+1.00
May 06, 2026GlobeNewsWireregulation
US FDA authorizes early access to Revolution's pancreatic cancer pill+1.00
May 01, 2026Reutersregulation